Literature DB >> 33936448

An Interpretable Machine Learning Survival Model for Predicting Long-term Kidney Outcomes in IgA Nephropathy.

Yingxue Li1, Tingyu Chen2, Tiange Chen1, Xiang Li1, Caihong Zeng2, Zhihong Liu2, Guotong Xie1.   

Abstract

IgA nephropathy (IgAN) is common worldwide and has heterogeneous phenotypes. Predicting long-term outcomes is important for clinical decision-making. As right-censored patients become common during the long-term follow-up, either excluding these patients from the cohort or labeling them as control will bias the risk estimation. Thus, we constructed a survival model using EXtreme Gradient Boosting for survival (XSBoost-Surv), to accurately predict the prognosis of IgAN patients by taking the time-to-event information into the modeling procedure. Shapley Additive exPlanations (SHAP) was employed to interpret the individual predicted result and the non-linear relationships between the predictors and outcome. Experiments on real-world data showed our model achieved superior discrimination performance over other conventional survival methods. By providing insights into the exact changes in risk induced by certain characteristics of the patients, this explainable and accurate survival model can help improve the clinical understanding of renal progression and benefit the therapies for the IgAN patients. ©2020 AMIA - All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33936448      PMCID: PMC8075445     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  22 in total

1.  Prediction of early progression in recently diagnosed IgA nephropathy.

Authors:  Kevin V Lemley; Richard A Lafayette; Geraldine Derby; Kristina L Blouch; Linda Anderson; Bradley Efron; Bryan D Myers
Journal:  Nephrol Dial Transplant       Date:  2007-09-22       Impact factor: 5.992

Review 2.  Machine Learning in Medicine.

Authors:  Alvin Rajkomar; Jeffrey Dean; Isaac Kohane
Journal:  N Engl J Med       Date:  2019-04-04       Impact factor: 91.245

Review 3.  Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.

Authors:  Hernán Trimarchi; Jonathan Barratt; Daniel C Cattran; H Terence Cook; Rosanna Coppo; Mark Haas; Zhi-Hong Liu; Ian S D Roberts; Yukio Yuzawa; Hong Zhang; John Feehally
Journal:  Kidney Int       Date:  2017-03-22       Impact factor: 10.612

4.  Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.

Authors:  WeiBo Le; ShaoShan Liang; YangLin Hu; KangPing Deng; Hao Bao; CaiHong Zeng; ZhiHong Liu
Journal:  Nephrol Dial Transplant       Date:  2011-09-29       Impact factor: 5.992

5.  A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.

Authors:  Tetsuya Kawamura; Kensuke Joh; Hideo Okonogi; Kentaro Koike; Yasunori Utsunomiya; Yoichi Miyazaki; Masato Matsushima; Mitsuhiro Yoshimura; Satoshi Horikoshi; Yusuke Suzuki; Akira Furusu; Takashi Yasuda; Sayuri Shirai; Takanori Shibata; Masayuki Endoh; Motoshi Hattori; Ritsuko Katafuchi; Akinori Hashiguchi; Kenjiro Kimura; Seiichi Matsuo; Yasuhiko Tomino
Journal:  J Nephrol       Date:  2012-06-07       Impact factor: 3.902

Review 6.  Risk stratification of patients with IgA nephropathy.

Authors:  Sean J Barbour; Heather N Reich
Journal:  Am J Kidney Dis       Date:  2012-04-11       Impact factor: 8.860

Review 7.  New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.

Authors:  Riccardo Magistroni; Vivette D D'Agati; Gerald B Appel; Krzysztof Kiryluk
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

8.  Unintended consequences of machine learning in medicine?

Authors:  Laura McDonald; Sreeram V Ramagopalan; Andrew P Cox; Mustafa Oguz
Journal:  F1000Res       Date:  2017-09-19

9.  A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study.

Authors:  Masashi Goto; Kenji Wakai; Takashi Kawamura; Masahiko Ando; Masayuki Endoh; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2009-06-10       Impact factor: 5.992

10.  Key challenges for delivering clinical impact with artificial intelligence.

Authors:  Christopher J Kelly; Alan Karthikesalingam; Mustafa Suleyman; Greg Corrado; Dominic King
Journal:  BMC Med       Date:  2019-10-29       Impact factor: 8.775

View more
  2 in total

1.  Short- and Long-Term Recovery after Moderate/Severe AKI in Patients with and without COVID-19.

Authors:  Siao Sun; Raji R Annadi; Imran Chaudhri; Kiran Munir; Janos Hajagos; Joel Saltz; Minh Hoai; Sandeep K Mallipattu; Richard Moffitt; Farrukh M Koraishy
Journal:  Kidney360       Date:  2021-11-29

2.  Using explainable machine learning to identify patients at risk of reattendance at discharge from emergency departments.

Authors:  F P Chmiel; D K Burns; M Azor; F Borca; M J Boniface; Z D Zlatev; N M White; T W V Daniels; M Kiuber
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.